Hospital
Richland Hospital
Richland Hospital was paid $9.23M by Medicaid between Jan 2018 and Dec 2024, across 171 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.
33Billing provider infoRICHLAND HOSPITAL
RICHLAND CENTER, WI 53581
RICHLAND CENTER, WI 53581
33aNPI1659301273assigned 07/03/2006
33bProvider typeCritical Access Hospital
28Total paid$9.23M
24GClaims263,295
24DCodes billed171
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Wisconsin
Rank by total paid#9 of 48
Median peer was paid$4.30M
This provider vs. median2.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,137 | $632K | |
| 2019 | 19,249 | $654K | |
| 2020 | 40,637 | $892K | |
| 2021 | 52,799 | $1.50M | |
| 2022 | 46,725 | $2.04M | |
| 2023 | 52,317 | $2.27M | |
| 2024incomplete | 31,431 | $1.24M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 14,186 | 10,896 | $2.10M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 14% | 6,159 | 5,191 | $1.27M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 32,458 | 18,815 | $1.25M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6.9% | 3,704 | 3,216 | $632K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.9% | 13,099 | 6,831 | $540K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.7% | 1,076 | 785 | $437K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.2% | 1,535 | 752 | $300K |
| 87631 | 2.9% | 3,766 | 3,262 | $271K | |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 1,005 | 776 | $246K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.3% | 6,332 | 3,585 | $210K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.0% | 8,359 | 2,820 | $183K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.7% | 693 | 548 | $158K |
159 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 3,398 | $113K |
| 99284 | Emergency room visit (serious) | 1.2% | 4,343 | $107K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,562 | $82K |
| 80053 | Comprehensive metabolic panel | <1% | 10,683 | $80K |
| G0378 | Hospital observation service, per hour | <1% | 426 | $73K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 806 | $70K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,706 | $56K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,468 | $54K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 312 | $41K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 506 | $41K |
| 80306 | <1% | 2,583 | $40K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 95 | $39K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,448 | $32K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,063 | $31K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 2,595 | $31K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,624 | $30K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,796 | $29K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,756 | $26K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 892 | $25K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 156 | $25K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 377 | $24K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,441 | $24K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 300 | $23K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 827 | $23K |
| 83880 | <1% | 2,378 | $22K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 80 | $22K |
| 90670 | <1% | 138 | $21K | |
| 80061 | Lipid panel | <1% | 2,464 | $20K |
| 81001 | <1% | 6,332 | $20K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,297 | $19K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 298 | $18K |
| 84484 | <1% | 3,726 | $16K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,518 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,697 | $14K |
| 90686 | <1% | 982 | $14K | |
| 11721 | <1% | 2,203 | $13K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 195 | $13K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,650 | $10K |
| 73630 | <1% | 612 | $10K | |
| 84145 | <1% | 1,503 | $10K | |
| 20610 | <1% | 38 | $9K | |
| 81025 | <1% | 1,296 | $9K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 43 | $9K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 76 | $9K |
| 36415 | Collection of venous blood by venipuncture | <1% | 22,486 | $9K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,727 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,439 | $8K |
| 0002A | <1% | 288 | $8K | |
| 97162 | <1% | 243 | $8K | |
| 83690 | <1% | 1,945 | $8K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 431 | $7K |
| 83605 | <1% | 1,840 | $7K | |
| 93356 | <1% | 14 | $7K | |
| 87077 | <1% | 1,440 | $7K | |
| 85610 | <1% | 2,743 | $6K | |
| 0001A | <1% | 264 | $6K | |
| 87186 | <1% | 1,145 | $6K | |
| 73562 | <1% | 312 | $6K | |
| 99307 | <1% | 1,093 | $5K | |
| 11056 | <1% | 195 | $5K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 31 | $5K |
| 99285 | Emergency room visit (most serious) | <1% | 271 | $5K |
| 85027 | <1% | 999 | $5K | |
| 83735 | <1% | 1,718 | $4K | |
| 87205 | <1% | 1,560 | $4K | |
| 87503 | <1% | 216 | $4K | |
| 82728 | <1% | 363 | $3K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 265 | $3K |
| 82803 | <1% | 442 | $3K | |
| 86140 | <1% | 1,246 | $3K | |
| 84703 | <1% | 367 | $3K | |
| 82962 | <1% | 1,659 | $3K | |
| 90723 | <1% | 117 | $3K | |
| 91320 | <1% | 55 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 140 | $3K |
| 90647 | <1% | 70 | $3K | |
| 86850 | <1% | 159 | $2K | |
| 90715 | <1% | 57 | $2K | |
| 87806 | <1% | 94 | $2K | |
| 87040 | <1% | 403 | $2K | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 197 | $2K |
| 82570 | <1% | 417 | $2K | |
| 90680 | <1% | 30 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 12 | $2K |
| Q3014 | Telehealth originating site facility fee | <1% | 349 | $2K |
| 85379 | <1% | 382 | $2K | |
| 87420 | <1% | 96 | $2K | |
| 86803 | <1% | 139 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 38 | $1K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 23 | $1K |
| 87634 | <1% | 23 | $1K | |
| 80050 | General health panel | <1% | 106 | $1K |
| 87070 | <1% | 163 | $1K | |
| 86780 | <1% | 129 | $1K | |
| 85730 | <1% | 513 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,585 | $929.20 |
| 82607 | <1% | 92 | $797.92 | |
| 0124A | <1% | 84 | $793.34 | |
| 72100 | <1% | 14 | $732.59 | |
| 11720 | <1% | 180 | $697.15 | |
| 73030 | <1% | 86 | $677.18 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 386 | $619.68 |
| 74018 | <1% | 46 | $606.10 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 37 | $550.13 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,777 | $547.72 |
| 0003A | <1% | 17 | $547.12 | |
| 87340 | <1% | 75 | $512.16 | |
| 73610 | <1% | 78 | $491.74 | |
| 99310 | Prolong nursin fac eval 15m | <1% | 29 | $434.55 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 178 | $421.96 |
| 82565 | <1% | 164 | $418.33 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,467 | $398.82 |
| 80329 | <1% | 81 | $385.47 | |
| 99335 | <1% | 25 | $340.92 | |
| 85651 | <1% | 129 | $334.62 | |
| G0008 | Administration of influenza virus vaccine | <1% | 267 | $304.02 |
| 87220 | <1% | 75 | $299.51 | |
| 83540 | <1% | 57 | $272.87 | |
| 99334 | <1% | 30 | $266.54 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 39 | $249.78 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 21 | $248.28 |
| 86900 | <1% | 121 | $244.41 | |
| 73502 | <1% | 15 | $240.78 | |
| 86901 | <1% | 121 | $234.84 | |
| 88142 | <1% | 16 | $203.95 | |
| 80320 | <1% | 356 | $192.70 | |
| 73110 | <1% | 16 | $188.40 | |
| 86762 | <1% | 15 | $163.57 | |
| 85018 | <1% | 51 | $153.51 | |
| 87905 | <1% | 15 | $151.96 | |
| 84460 | <1% | 48 | $127.66 | |
| 84153 | <1% | 14 | $125.28 | |
| 96376 | <1% | 227 | $125.18 | |
| 97161 | <1% | 12 | $113.49 | |
| 90662 | <1% | 62 | $111.77 | |
| 99441 | <1% | 26 | $103.95 | |
| 87081 | <1% | 35 | $81.58 | |
| 82043 | <1% | 16 | $78.09 | |
| J2704 | Injection, propofol, 10 mg | <1% | 865 | $76.68 |
| 85652 | <1% | 42 | $75.33 | |
| 94664 | <1% | 65 | $69.63 | |
| 82150 | <1% | 14 | $60.30 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 610 | $56.08 |
| 84439 | <1% | 17 | $37.28 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,168 | $36.28 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,691 | $31.77 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 635 | $23.80 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 308 | $17.41 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 242 | $8.58 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 233 | $8.53 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 72 | $8.15 |
| A9270 | Non-covered item or service | <1% | 232 | $6.21 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 33 | $3.46 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 51 | $2.80 |
| A4217 | Sterile water/saline, 500 ml | 0% | 89 | $0.00 |
| 91300 | 0% | 184 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 14 | $0.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 13 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMYERS, LANA (MANAGER PATIENT ACCOUNTING)
| Provider | Location | Paid |
|---|---|---|
| Richland Hospital | Richland Center, WI | $34K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.